Annual report pursuant to Section 13 and 15(d)

Stockholders' (Deficit) Equity (Tables)

v3.20.4
Stockholders' (Deficit) Equity (Tables)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Equity [Abstract]    
Summary of Nonvested Restricted Stock Shares Activity
Restricted stock activity for the years ended December 31, 2020 and 2019 is summarized as follows:
Number of Shares Weighted-Average Grant Date Fair Value
Unvested at December 31, 2018
127,500  $ 3.21 
  Granted 200,000  11.54 
  Vested (169,164) 5.26 
Unvested at December 31, 2019
158,336  $ 11.54 
  Granted 200,000  7.16 
  Vested (49,992) 11.54 
Unvested at December 31, 2020
308,344  $ 8.70 
 
Summary of Stock Option Activity  
The following table summarizes stock option activities for the years ended December 31, 2020 and 2019:
Number of
Shares
Weighted
Average
Exercise Price
Weighted
Average
Remaining Life
(in Years)
Aggregate
Intrinsic Value
Outstanding, December 31, 2018
2,235,000  $ 1.74  9.44 $ 23,100 
  Granted 648,550  6.03  —  — 
Outstanding, December 31, 2019
2,883,550  2.70  8.62 $ 23,861,981 
  Granted 1,036,000  9.38  —  — 
Outstanding, December 31, 2020
3,919,550  $ 4.47  8.11 $ 13,095,054 
Exercisable, December 31, 2020
1,627,425 $ 2.47  7.59 $ 8,696,368 
Summary of Warrant Activity
The following table summarizes warrant activities for the years ended December 31, 2020 and 2019:
Number of
Shares
Weighted
Average
Exercise Price
Weighted
Average
Remaining Contractual
Term (in Years)
Aggregate
Intrinsic Value
Outstanding, December 31, 2018
776,350  $ 1.75  4.80 $ — 
Granted 1,458,356  10.88  —  — 
Exercised (685,900) 2.12  —  6,073,855 
Forfeited (cashless exercise) (174,198) 3.99  —  — 
Outstanding, December 31, 2019 1,374,608  $ 10.97  4.43 $ 13,591 
Exercised (40,891) 1.75  —  247,799 
Forfeited (cashless exercise) (9,109) 1.75  —  — 
Outstanding December 31, 2020 1,324,608  $ 11.32  3.44 $  
Exercisable, December 31, 2020 1,324,608  $ 11.32  3.44 $